Posts by Sandra Ansanay-Alex
MoleSens Wins The EPFL Startup Champion Seed Night
On April 10th, 2025, the Startup Champions Seed Night once again confirmed its place as a cornerstone event in Western Switzerland’s innovation landscape. Co-organized by EPFL Alumni, the EPFL Vice Presidency for Innovation, and Venturelab, the 14th edition brought together nearly 500 attendees—both in person at the Rolex Forum and online—to celebrate the next generation…
Read MoreNovigenix awarded EUR 1.8 Million
Novigenix is part of the groundbreaking BRECISE IHI Consortium to industrialize AI-powered liquid biopsy for prediction of immunotherapy response. Novigenix, a Vaud-Based leader in AI-driven precision liquid biopsy solutions, has been awarded EUR 1.8M through the new BRECISE IHI grant funded by the European Union (EU) research initiative focusing on revolutionizing cancer diagnostics, treatment, and…
Read More2024: A Year of Growth and Innovation at Biopôle
2024 was a landmark year for Biopôle-based companies, underscoring the campus’s reputation as a premier hub for life sciences innovation. With over CHF 246 million secured in funding, 25 new companies joining, significant commercial partnerships, and groundbreaking research advancements, Biopôle has been cultivating for 20 years a thriving ecosystem that propels healthcare and biotechnology forward.…
Read MoreProf. Li Tang Receives a Foundation Leenaards Prize
Professor Li Tang (EPFL), is exploring a new approach to overcoming the resistance of cancer cells to immunotherapeutic treatments. By strengthening the rigidity of cancer cells, the researchers hope to improve the effectiveness of T lymphocytes in eliminating tumours. This breakthrough, combining mechanical engineering, biology and clinical research, could lead to more effective treatments for…
Read MoreDr. Jasmine Abdulcadir Wins Leenaards Scientific Prize
Dr. Jasmine Abdulcadir (HUG) in collaboration with Prof. Daniel Huber (UNIGE), focuses on improving the understanding and evaluation of female genital sensitivity, a field still lacking in objective clinical tools—particularly in the context of female genital mutilation (FGM). A pioneering portable, connected device will be developed to allow women to assess the sensitivity of…
Read MoreSOPHiA GENETICS Announces Two Million Patient Cases Analysed
SOPHiA GENETICS, a cloud-native software company based in canton of Vaud (Switzerland) and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analysed on the AI-powered analytics Platform SOPHiA DDM™. “When we announced one million profiles analysed in 2022, it was a landmark moment in the…
Read MoreBloom Biorenewables Raises CHF 13 Million
Fribourg-based startup Bloom Biorenewables SA, a pioneer in the conversion of biomass into sustainable alternatives to petroleum-based products, has successfully closed a CHF 13 million funding round. This milestone will enable the company to accelerate its growth and take a major step toward building its first industrial-scale facility by 2027. Led by Anaïs Ventures and…
Read MoreThe CHUV inaugurates the new Children’s Hospital
The new Children’s Hospital opens on 14 May 2025 at the end of a complex construction project that began in 2019 in the heart of Lausanne’s hospital district. The building will bring together the majority of the CHUV’s paediatric activities, currently spread over two sites, in a place designed specifically to meet the needs of…
Read MoreArtiria Medical and Reverso Therapeutics Awarded at BIND – BioInnovation Day
250 key players of the Swiss Health Valley gathered at Campus Biotech Geneva on 1 April 2025 for the 10th edition of BIND-BioInnovation Day. 29 groundbreaking life sciences projects developed in Western Switzerland Academic Institutions pitched in front of the audience. Artiria Medical and Reverso Therapeutics won the Best Startup Award and the Best Academic…
Read MoreArkaiya receive support from FIT
The Fondation for Innovation Technologique is announcing support for three new start-ups, among them, a Tech Seed loans worth CHF 100,000 to Arkaiya for its innovative nutrition system. Over the last ten years, research into the microbiome has exploded because of its links with numerous diseases. The development of the microbiome, which takes place…
Read More